MIRVETUXIMAB SORAVTANSINE

1814 reported adverse events

These side effects are most commonly reported by patients taking MIRVETUXIMAB SORAVTANSINE:

# Side effect Count
0 DEATH 131
1 NEUROPATHY PERIPHERAL 120
2 VISION BLURRED 120
3 DISEASE PROGRESSION 108
4 DIARRHOEA 103
5 ABDOMINAL PAIN 101
6 NAUSEA 97
7 PNEUMONITIS 95
8 CATARACT 90
9 FATIGUE 68
See all common reactions for MIRVETUXIMAB SORAVTANSINE

MIRVETUXIMAB SORAVTANSINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HIGH GRADE SEROUS OVARIAN CARCINOMA 10 0.5263
1 OVARIAN EPITHELIAL CANCER 13 0.0681
2 EYE ABRASION 3 0.0566
3 CORNEAL EPITHELIAL MICROCYSTS 8 0.0479
4 OCULAR TOXICITY 46 0.0417
5 KERATOPATHY 60 0.0379
6 CORNEAL CYST 3 0.0309
7 CORNEAL TOXICITY 3 0.0270
8 KERATITIS 55 0.0181
9 CORNEAL DEPOSITS 12 0.0161
See all enriched reactions for MIRVETUXIMAB SORAVTANSINE